NR 566 MIDTERM/NR566 ADVANCED
PHARMACOLOGY FOR CARE OF THE FAMILY
MIDTERM EXAM 290 QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS)
PLUS RATIONALES 2026/2027 Q&A | ALREADY
GRADED A+ | INSTANT DOWNLOAD PDF.
This Photo by Unknown Author is licensed original
Core Domains
Pharmacokinetics and Pharmacodynamics
Pharmacotherapy for Fungal Infections
Pharmacotherapy for Viral Infections
Pharmacotherapy for Bacterial Infections
Pharmacotherapy for Urinary Conditions
Pharmacotherapy for Gender-Related Health
Drug Interactions and CYP450 System
Special Populations: Pregnancy, Pediatrics, and Geriatrics
Prescribing Considerations and Patient Education
Antimicrobial Stewardship and Resistance
Introduction
This comprehensive assessment is designed to evaluate the advanced
pharmacological knowledge and clinical decision-making skills of
graduate-level family nurse practitioner students at Chamberlain
,University. It covers critical domains including pharmacokinetics,
pharmacodynamics, antifungal, antiviral, antibacterial, and urinary
pharmacotherapy, gender-related health, drug interactions, and special
populations. The exam assesses proficiency in drug mechanisms,
monitoring parameters, patient education, and evidence-based
prescribing. Featuring multiple-choice and scenario-based questions, it
emphasizes real-world clinical application, safety, and patient-centered
care. Candidates must demonstrate sound clinical judgment and a
thorough understanding of advanced pharmacology for autonomous
family nurse practitioner practice.
Section One: Questions 1–290
1. Which process describes what the body does to a drug, including
absorption, distribution, metabolism, and excretion?
A. Pharmacodynamics
B. Pharmacogenetics
C. Pharmacokinetics
D. Pharmacotherapeutics
Correct answer: C
RATIONALE: Pharmacokinetics refers to the movement of a drug
through the body (what the body does to the drug), encompassing
absorption, distribution, metabolism, and excretion. Pharmacodynamics
is what the drug does to the body.
2. A patient with a low serum albumin level is prescribed a highly
protein-bound drug. What is the main concern for this patient?
A. Rapid renal excretion
B. Decreased therapeutic effect
,C. Increased risk of drug toxicity
D. Reduced drug absorption
Correct answer: C
RATIONALE: Low albumin means fewer binding sites, leading to
more free (active) drug in the bloodstream, which increases the risk of
toxicity.
3. Which enzyme system in the liver is most commonly responsible
for the metabolism of the majority of drugs?
A. MAO system
B. Cholinesterase system
C. Glucuronidation system
D. Cytochrome P450 system
Correct answer: D
RATIONALE: The Cytochrome P450 (CYP450) enzyme system is
the primary pathway for hepatic drug metabolism.
4. What is the primary site of drug excretion in the human body?
A. Kidneys
B. Liver
C. Lungs
D. Skin
Correct answer: A
RATIONALE: While some drugs are excreted via bile or sweat, the
kidneys are the main organ responsible for drug excretion.
5. Which of the following describes the 'First-Pass Effect'?
, A. Rapid renal clearance of a drug after the first dose
B. The binding of a drug to plasma proteins
C. Metabolism of an oral drug in the liver before reaching systemic
circulation
D. The time it takes for a drug to reach steady state
Correct answer: C
RATIONALE: Oral drugs are absorbed in the GI tract and pass
through the liver via the portal vein, where they may be significantly
metabolized before entering systemic circulation.
6. How many half-lives does it typically take for a drug to reach
steady-state concentration?
A. 1 to 2
B. 2 to 3
C. 4 to 5
D. 7 to 10
Correct answer: C
RATIONALE: It generally takes 4 to 5 half-lives for a drug to reach
a plateau or steady-state concentration in the plasma.
7. A patient is diagnosed with systemic coccidioidomycosis. Which
antifungal agent is administered intravenously and binds to
ergosterol in the fungal cell membrane to increase permeability?
A. Fluconazole
B. Amphotericin B
C. Terbinafine
D. Griseofulvin
Correct answer: B
PHARMACOLOGY FOR CARE OF THE FAMILY
MIDTERM EXAM 290 QUESTIONS AND
CORRECT ANSWERS (VERIFIED ANSWERS)
PLUS RATIONALES 2026/2027 Q&A | ALREADY
GRADED A+ | INSTANT DOWNLOAD PDF.
This Photo by Unknown Author is licensed original
Core Domains
Pharmacokinetics and Pharmacodynamics
Pharmacotherapy for Fungal Infections
Pharmacotherapy for Viral Infections
Pharmacotherapy for Bacterial Infections
Pharmacotherapy for Urinary Conditions
Pharmacotherapy for Gender-Related Health
Drug Interactions and CYP450 System
Special Populations: Pregnancy, Pediatrics, and Geriatrics
Prescribing Considerations and Patient Education
Antimicrobial Stewardship and Resistance
Introduction
This comprehensive assessment is designed to evaluate the advanced
pharmacological knowledge and clinical decision-making skills of
graduate-level family nurse practitioner students at Chamberlain
,University. It covers critical domains including pharmacokinetics,
pharmacodynamics, antifungal, antiviral, antibacterial, and urinary
pharmacotherapy, gender-related health, drug interactions, and special
populations. The exam assesses proficiency in drug mechanisms,
monitoring parameters, patient education, and evidence-based
prescribing. Featuring multiple-choice and scenario-based questions, it
emphasizes real-world clinical application, safety, and patient-centered
care. Candidates must demonstrate sound clinical judgment and a
thorough understanding of advanced pharmacology for autonomous
family nurse practitioner practice.
Section One: Questions 1–290
1. Which process describes what the body does to a drug, including
absorption, distribution, metabolism, and excretion?
A. Pharmacodynamics
B. Pharmacogenetics
C. Pharmacokinetics
D. Pharmacotherapeutics
Correct answer: C
RATIONALE: Pharmacokinetics refers to the movement of a drug
through the body (what the body does to the drug), encompassing
absorption, distribution, metabolism, and excretion. Pharmacodynamics
is what the drug does to the body.
2. A patient with a low serum albumin level is prescribed a highly
protein-bound drug. What is the main concern for this patient?
A. Rapid renal excretion
B. Decreased therapeutic effect
,C. Increased risk of drug toxicity
D. Reduced drug absorption
Correct answer: C
RATIONALE: Low albumin means fewer binding sites, leading to
more free (active) drug in the bloodstream, which increases the risk of
toxicity.
3. Which enzyme system in the liver is most commonly responsible
for the metabolism of the majority of drugs?
A. MAO system
B. Cholinesterase system
C. Glucuronidation system
D. Cytochrome P450 system
Correct answer: D
RATIONALE: The Cytochrome P450 (CYP450) enzyme system is
the primary pathway for hepatic drug metabolism.
4. What is the primary site of drug excretion in the human body?
A. Kidneys
B. Liver
C. Lungs
D. Skin
Correct answer: A
RATIONALE: While some drugs are excreted via bile or sweat, the
kidneys are the main organ responsible for drug excretion.
5. Which of the following describes the 'First-Pass Effect'?
, A. Rapid renal clearance of a drug after the first dose
B. The binding of a drug to plasma proteins
C. Metabolism of an oral drug in the liver before reaching systemic
circulation
D. The time it takes for a drug to reach steady state
Correct answer: C
RATIONALE: Oral drugs are absorbed in the GI tract and pass
through the liver via the portal vein, where they may be significantly
metabolized before entering systemic circulation.
6. How many half-lives does it typically take for a drug to reach
steady-state concentration?
A. 1 to 2
B. 2 to 3
C. 4 to 5
D. 7 to 10
Correct answer: C
RATIONALE: It generally takes 4 to 5 half-lives for a drug to reach
a plateau or steady-state concentration in the plasma.
7. A patient is diagnosed with systemic coccidioidomycosis. Which
antifungal agent is administered intravenously and binds to
ergosterol in the fungal cell membrane to increase permeability?
A. Fluconazole
B. Amphotericin B
C. Terbinafine
D. Griseofulvin
Correct answer: B
